Share：
Share this content in WeChat
X
[Chinese][PDF]735110
• Review •
Functional magnetic resonance imaging in early noninvasive diagnosis of prostate cancer
ZHANG Na  CHEN Min  LIU Xin 

DOI:10.3969/j.issn.1674-8034.2010.04.016.


[Abstract] In recent years, the application of functional magnetic resonance imaging (MRI) techniques include diffusion weighted imaging (DWI), dynamic contrast-enhanced MR imaging (DCE-MRI) and MR spectroscopy (MRS) have demonstrated great potentials to improve the diagnosis accuracy for prostate cancer in early stage. In this paper, we reviewed the state-of-the art of the functional MRI techniques in the early diagnosis of prostate cancer.
[Keywords] Diffusion weighted imaging；Dynamic contrast-enhancement；Magnetic resonance spectroscopy；Prostate neoplasms

ZHANG Na Paul C. Lauterbur Research Centre for Biomedical Imaging, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Science, Shenzhen 518055, China; Key Lab for Biomedical Informatics and Health Engineering, Chinese Academy of Sciences, Shenzhen 518055, China

CHEN Min Department of Radiology, Beijing Hospital, Beijing 100730, China

LIU Xin* Paul C. Lauterbur Research Centre for Biomedical Imaging, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Science, Shenzhen 518055, China; Key Lab for Biomedical Informatics and Health Engineering, Chinese Academy of Sciences, Shenzhen 518055, China

*Correspondence to: Liu X, E-mail: xin.liu@sub.siat.ac.cn

Conflicts of interest   None.

Received  2010-06-15
Accepted  2010-07-05
DOI: 10.3969/j.issn.1674-8034.2010.04.016
DOI:10.3969/j.issn.1674-8034.2010.04.016.

[1]
Morakkabati-Spitz N, Bastian PJ, Gieseke J, et al. MR imaging of the prostate at 3.0T with external phased array coil-preliminary results. Eur J Med Res, 2008, 13(6): 287-291.
[2]
Shimizu T, Nishie A, Ro T, et al. Prostate cancer detection: the value of performing an MRI before a biopsy. Acta Radiol, 2009, 50(9):1080-1088.
[3]
Hricak H, Choyke PL, Eberhardt SC, et al. Imaging prostate cancer: a multidisciplinary perspective. Radiology, 2007, 243(1): 28-53.
[4]
Kitajima K, Kaji Y, Fukabori Y, et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging, 2010, 31(3):625-631.
[5]
Langer DL, van der Kwast TH, Evans AJ, et al. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging, 2009, 30(2):327-334.
[6]
Choi YJ, Kim JK, Kim N, et al. Functional MR imaging of prostate cancer. Radiographics, 2007, 27(1):63-75.
[7]
Jacobs MA, Ouwerkerk R, Petrowski K, et al. Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer. Top Magn Reson Imaging, 2008, 19(6):261-272.
[8]
Kim JK, Jang YJ, Cho G, Multidisciplinary functional MR imaging for prostate cancer. Korean J Radiol, 2009, 10(6):535-551.
[9]
DeSouza NM, Riches SF, Vanas NJ, et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol, 2008, 63(7):774-782.
[10]
Ren J, Huan Y, Li F, et al. Combined T2-Weighted and Diffusion-Weighted MRI for Diagnosis of Urinary Bladder Invasion in Patients with Prostate Carcinoma. J Magn Reson Imaging, 2009, 30(2):351-356.
[11]
Ren J, Huan Y, Wang H, et al. Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol, 2009, 19(10):2481-2486.
[12]
Lim HK, Kim JK, Kim KA, et al. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection-a multireader study. Radiology, 2009, 250(1):145-151.
[13]
Morgan VA, Kyriazi S, Ashley SE, et al. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol, 2007, 48(6):695-703.
[14]
Haider MA, van der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol, 2007, 189(2): 323-328.
[15]
Kim JK, Hong SS, Choi YJ, et al. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. J Magn Reson Imaging, 2005, 22(5):639-646.
[16]
Jackson MW, Bentel JM, Tilley WD. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol, 1997, 157(6):2323-2328.
[17]
Tofts PS, Brix G, Buckley DL, et al. Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols. J Magn Reson Imaging, 1999, 10(3):223-232.
[18]
Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology, 2006, 241(2):449-458.
[19]
Buckley DL, Roberts C, Parker GJ, et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging - initial experience. Radiology, 2004, 233(3):709-715.
[20]
Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology, 2003, 229(1):248-254.
[21]
Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med, 2002, 47(3):601-606.
[22]
Vos PC, Hambrock T, Hulsbergen-van DKC, et al. Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI. Med Phys, 2008, 35(3):888-899.
[23]
Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology, 2005, 234(3):804-814.
[24]
Shukla-Dave A, Hricak H, Kattan MW, et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int, 2007, 99(4):786-793.
[25]
Mark J. Albers, Robert Bok, Albert P. Chen, et al. Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading. Cancer Res, 2008, 68(20):8607-8615.
[26]
Kim CK, Park BK, Kim B. Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrastenhanced imaging. J Comput Assist Tomogr, 2006, 30(1):7-11.
[27]
Kim CK, Park BK, Kim B. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol, 2010, 194(1):W33-7.
[28]
Kim CK, Park BK, Park W, et al. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Abdom Imaging, 2010, 35(2):246-252.
[29]
Kim CK, Park BK, Lee HM. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging, 2009, 29(2):391-397.
[30]
Cirillo S, Petracchini M, Della MP, et al. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours. Clin Radiol, 2008, 63(8):871-879.

PREV Solitary plasmacytoma forming a mass in the epidural space of the spinal cord: one case report
NEXT
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn